Showing results (721-730 of 772) with videos related to

Sort By:
Pageof 78
Plos Pathogens|December 18, 2020
Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiologyM Foulon, M Robbe-Saule, J Manry, et al.
Lancet (London, England)|November 23, 2024
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial designAlberto Bossi, Stéphanie Foulon, Xavier Maldonado, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trialAdrien Rousseau, Maryam Karimi, Stefan Michiels, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 29, 2022
Subclavian versus femoral arterial cannulations during extracorporeal membrane oxygenation: A propensity-matched comparisonMouhamed Djahoum Moussa, Natacha Rousse, Osama Abou Arab, et al.
Environmental Microbiology|May 14, 2013
Soil metatranscriptomics for mining eukaryotic heavy metal resistance genesFrédéric Lehembre, Didier Doillon, Elise David, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidasesSabrina Urban, Kathrin Textoris-Taube, Barbara Reimann, et al.
Acta Neurologica Belgica|December 7, 2011
Epileptic syndromes: differential treatment in infants, children, and adolescentsM Foulon, A Aeby, M Buzatu, et al.
Nature Genetics|April 12, 2022
H3K27me3 conditions chemotolerance in triple-negative breast cancerJustine Marsolier, Pacôme Prompsy, Adeline Durand, et al.
European Urology Oncology|July 21, 2024
The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 TrialsShanna Rajpar, Tony Ibrahim, Alexandra Carmel, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2004
SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm laborClaudine Serradeil-Le Gal, Gérard Valette, Loïc Foulon, et al.
Pageof 78